96 related articles for article (PubMed ID: 1983344)
1. Loss of acid suppression during dosing with H2-receptor antagonists.
Wilder-Smith C; Halter F; Ernst T; Gennoni M; Zeyen B; Varga L; Roehmel JJ; Merki HS
Aliment Pharmacol Ther; 1990; 4 Suppl 1():15-27. PubMed ID: 1983344
[TBL] [Abstract][Full Text] [Related]
2. The effects of 15 days of dosing with placebo, sufotidine 600 mg nocte or sufotidine 600 mg twice daily upon 24-hour intragastric acidity and 24-hour plasma gastrin.
Rogers MJ; Holmfield JH; Primrose JN; Johnston D
Aliment Pharmacol Ther; 1990; 4 Suppl 1():65-74. PubMed ID: 1983347
[TBL] [Abstract][Full Text] [Related]
3. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
Nwokolo CU; Smith JT; Gavey C; Sawyerr A; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():29-45. PubMed ID: 1983345
[TBL] [Abstract][Full Text] [Related]
4. Tolerance during 8 days of high-dose H2-blockade: placebo-controlled studies of 24-hour acidity and gastrin.
Smith JT; Gavey C; Nwokolo CU; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():47-63. PubMed ID: 1983346
[TBL] [Abstract][Full Text] [Related]
5. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration.
Lachman L; Howden CW
Am J Gastroenterol; 2000 Jan; 95(1):57-61. PubMed ID: 10638559
[TBL] [Abstract][Full Text] [Related]
6. Chronic administration of H2-antagonists does not alter gastric secretory responses to histamine, or the antisecretory activity of sufotidine.
Stables R; Humphray JM; Reeves JJ
Aliment Pharmacol Ther; 1990; 4 Suppl 1():7-13. PubMed ID: 1983348
[TBL] [Abstract][Full Text] [Related]
7. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
[TBL] [Abstract][Full Text] [Related]
8. Intravenous pentagastrin can induce the illusion of 'tolerance' to a single dose of an H2-blocker in man.
Nwokolo CU; Sawyerr A; Smith JT; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():75-83. PubMed ID: 1983349
[TBL] [Abstract][Full Text] [Related]
9. Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine.
Dammann HG; Gottlieb WR; Walter TA; Dreyer M; Müller P; Simon B; Keohane P
Hepatogastroenterology; 1986 Oct; 33(5):217-20. PubMed ID: 2879782
[TBL] [Abstract][Full Text] [Related]
10. Effect of oral famotidine on 24-hour intragastric acidity.
Santana IA; Lanzon-Miller S; Pounder RE
Postgrad Med J; 1986; 62 Suppl 2():39-42. PubMed ID: 2890150
[TBL] [Abstract][Full Text] [Related]
11. Acute effects of ranitidine, famotidine and omeprazole on plasma gastrin in the rat.
Decktor DL; Pendleton RG; Kellner AT; Davis MA
J Pharmacol Exp Ther; 1989 Apr; 249(1):1-5. PubMed ID: 2565384
[TBL] [Abstract][Full Text] [Related]
12. Marked rebound acid hypersecretion after treatment with ranitidine.
el-Omar E; Banerjee S; Wirz A; Penman I; Ardill JE; McColl KE
Am J Gastroenterol; 1996 Feb; 91(2):355-9. PubMed ID: 8607506
[TBL] [Abstract][Full Text] [Related]
13. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
14. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
Netzer P; Gaia C; Sandoz M; Huluk T; Gut A; Halter F; Hüsler J; Inauen W
Am J Gastroenterol; 1999 Feb; 94(2):351-7. PubMed ID: 10022628
[TBL] [Abstract][Full Text] [Related]
15. Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole.
Hurlimann S; Abbühl B; Inauen W; Halter F
Aliment Pharmacol Ther; 1994 Apr; 8(2):193-201. PubMed ID: 8038351
[TBL] [Abstract][Full Text] [Related]
16. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
Kakuda TN; Falcon RW
Pharmacotherapy; 2006 Aug; 26(8):1060-8. PubMed ID: 16863482
[TBL] [Abstract][Full Text] [Related]
17. Effect of three single doses of oxmetidine administered intravenously on the volume and acidity of gastric secretion, serum prolactin and gastrin concentration in healthy volunteers.
Wichmann GC; Fölsch UR; von Kleist E; Hasse FM; Dillon M; Clowdus B; Creutzfeldt W
Z Gastroenterol; 1984 Jun; 22(6):285-93. PubMed ID: 6147051
[TBL] [Abstract][Full Text] [Related]
18. The effects of roxatidine acetate on 24-hour intragastric acidity. Investigations in healthy volunteers and comparison with ranitidine and placebo.
Merki HS; Witzel L; Kaufmann D; Kempf M; Neumann J; Scheurle E; Röhmel J; Walt RP
Drugs; 1988; 35 Suppl 3():69-75. PubMed ID: 2905252
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of gastric secretion following single morning or twice daily oral administration of sufotidine to volunteers.
Johnston DA; Wormsley KG
Br J Clin Pharmacol; 1989 Oct; 28(4):403-7. PubMed ID: 2574050
[TBL] [Abstract][Full Text] [Related]
20. The effects of roxatidine acetate (HOE-760) on 24-hour intragastric acidity in healthy volunteers: comparison with ranitidine and placebo.
Merki HS; Witzel L; Kaufmann D; Kempf M; Müssig V; Neumann J; Scheurle E; Röhmel J; Walt RP
Aliment Pharmacol Ther; 1988 Feb; 2(1):73-81. PubMed ID: 2908751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]